{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:45:59Z","timestamp":1790145959030,"version":"4.0.1"},"reference-count":82,"publisher":"Impact Journals, LLC","issue":"47","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,11,22]]},"DOI":"10.18632\/oncotarget.12784","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T23:31:40Z","timestamp":1477006300000},"page":"77052-77070","source":"Crossref","is-referenced-by-count":24,"title":["Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer"],"prefix":"10.18632","volume":"7","author":[{"given":"Mijung","family":"Kwon","sequence":"first","affiliation":[{"name":"Department of Surgery, Albert Einstein College of Medicine, Bronx, NY 10461, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 135-720, Korea"},{"name":"Institute of Women's Life Medical Science, Yonsei University College of Medicine, Seoul 135-720, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yevangelina","family":"Rybak","sequence":"additional","affiliation":[{"name":"Department of Surgery, Albert Einstein College of Medicine, Bronx, NY 10461, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Luna","sequence":"additional","affiliation":[{"name":"Department of Surgery, Albert Einstein College of Medicine, Bronx, NY 10461, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chel Hun","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, Korea"},{"name":"Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon-Yong","family":"Chung","sequence":"additional","affiliation":[{"name":"Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Hewitt","sequence":"additional","affiliation":[{"name":"Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Adem","sequence":"additional","affiliation":[{"name":"Department of Surgery, Albert Einstein College of Medicine, Bronx, NY 10461, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Tubridy","sequence":"additional","affiliation":[{"name":"Department of Surgery, Albert Einstein College of Medicine, Bronx, NY 10461, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven K.","family":"Libutti","sequence":"additional","affiliation":[{"name":"Department of Surgery, Albert Einstein College of Medicine, Bronx, NY 10461, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,10,20]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Jemal","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"Davidson","year":"1996","journal-title":"N Engl J Med"},{"key":"3","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Montz","year":"2002","journal-title":"J Clin Oncol"},{"key":"4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrc2583","article-title":"Beyond chemotherapy: targeted therapies in ovarian cancer","volume":"9","author":"Kaye","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tem.2009.08.005","article-title":"WNT signaling in ovarian follicle biology and tumorigenesis","volume":"21","author":"Boerboom","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"6","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/sj.bjc.6601265","article-title":"Wnt-signalling pathway in ovarian epithelial tumours: increased expression of beta-catenin and GSK3beta","volume":"89","author":"Sundfeldt","year":"2003","journal-title":"Br J Cancer"},{"key":"7","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1525-1438.2007.01127.x","article-title":"Wnt signaling in ovarian tumorigenesis","volume":"18","author":"Holcombe","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"8","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ygyno.2013.09.034","article-title":"Buchsbaum DJ. The Wnt\/beta-catenin pathway in ovarian cancer: a review","volume":"131","author":"Straughn","year":"2013","journal-title":"Gynecol Oncol"},{"key":"9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20110112","article-title":"Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment","volume":"437","author":"Stack","year":"2011","journal-title":"Biochem J"},{"key":"10","first-page":"2714","article-title":"The many faces and functions of beta-catenin","volume":"31","author":"Basler","year":"2012","journal-title":"EMBO J"},{"key":"11","first-page":"264","article-title":"Overexpression of beta-catenin and cyclinD1 predicts a poor prognosis in ovarian serous carcinomas","volume":"7","author":"Wang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"12","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/IGC.0b013e3181aaa93a","article-title":"Expression profiles of genes involved in poor prognosis of epithelial ovarian carcinoma: a review","volume":"19","author":"Kobayashi","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0090-8258(02)00015-X","article-title":"beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma","volume":"88","author":"Lu","year":"2003","journal-title":"Gynecol Oncol"},{"key":"14","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ejca.2005.01.022","article-title":"beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients","volume":"41","author":"Danielsen","year":"2005","journal-title":"Eur J Cancer"},{"key":"15","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/0272-6386(95)90610-X","article-title":"Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced","volume":"26","author":"Zuk","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"16","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Weinberg","year":"2009","journal-title":"J Clin Invest"},{"key":"17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc2620","article-title":"Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits","volume":"9","author":"Weinberg","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12943-016-0502-x","article-title":"Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications","volume":"15","author":"Alahari","year":"2016","journal-title":"Mol Cancer"},{"key":"19","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1096\/fj.12-222620","article-title":"Tissue transglutaminase regulates beta-catenin signaling through a c-Src-dependent mechanism","volume":"27","author":"Matei","year":"2013","journal-title":"FASEB J"},{"key":"20","doi-asserted-by":"crossref","first-page":"e78200","DOI":"10.1371\/journal.pone.0078200","article-title":"The role of nuclear beta-catenin accumulation in the Twist2-induced ovarian cancer EMT","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ijc.25083","article-title":"Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway","volume":"127","author":"Yu","year":"2010","journal-title":"Int J Cancer"},{"key":"22","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1038\/onc.2011.123","article-title":"MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma","volume":"30","author":"Cho","year":"2011","journal-title":"Oncogene"},{"key":"23","doi-asserted-by":"crossref","first-page":"e54362","DOI":"10.1371\/journal.pone.0054362","article-title":"The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells","volume":"8","author":"Ward","year":"2013","journal-title":"PLoS One"},{"key":"24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Weinberg","year":"2000","journal-title":"Cell"},{"key":"25","first-page":"33","article-title":"Epithelial-mesenchymal transition in ovarian carcinoma","volume":"2","author":"Reich","year":"2012","journal-title":"Front Oncol"},{"key":"26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2009.09.017","article-title":"Epithelial-mesenchymal transition in ovarian cancer","volume":"291","author":"Salzet","year":"2010","journal-title":"Cancer Lett"},{"key":"27","first-page":"510","article-title":"Characterization of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes","volume":"71","author":"Kruk","year":"1994","journal-title":"Lab Invest"},{"key":"28","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10585-008-9171-5","article-title":"Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression","volume":"25","author":"Stack","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-0-387-98094-2_15","article-title":"Microenvironmental regulation of ovarian cancer metastasis","volume":"149","author":"Stack","year":"2009","journal-title":"Cancer Treat Res"},{"key":"30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1432-0436.2007.00193.x","article-title":"The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression","volume":"76","author":"Roskelley","year":"2008","journal-title":"Differentiation"},{"key":"31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00428-011-1082-1","article-title":"The cadherin switch in ovarian high-grade serous carcinoma is associated with disease progression","volume":"459","author":"Deen","year":"2011","journal-title":"Virchows Arch"},{"key":"32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.bjc.6604115","article-title":"The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients","volume":"98","author":"Becker","year":"2008","journal-title":"Br J Cancer"},{"key":"33","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/j.1349-7006.2008.00946.x","article-title":"Establishment of an ovarian metastasis model and possible involvement of E-cadherin down-regulation in the metastasis","volume":"99","author":"Sakamoto","year":"2008","journal-title":"Cancer Sci"},{"key":"34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00795-008-0436-5","article-title":"Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression","volume":"42","author":"Konishi","year":"2009","journal-title":"Med Mol Morphol"},{"key":"35","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/ijc.24901","article-title":"Snail is critical for tumor growth and metastasis of ovarian carcinoma","volume":"126","author":"Feng","year":"2010","journal-title":"Int J Cancer"},{"key":"36","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/156800910791190175","article-title":"Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer","volume":"10","author":"Quinn","year":"2010","journal-title":"Curr Cancer Drug Targets"},{"key":"37","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ejca.2012.06.026","article-title":"Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer","volume":"49","author":"Torri","year":"2013","journal-title":"Eur J Cancer"},{"key":"38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1757-2215-6-49","article-title":"Molecular profiling supports the role of epithelial-to-mesenchymal transition (EMT) in ovarian cancer metastasis","volume":"6","author":"McDonald","year":"2013","journal-title":"J Ovarian Res"},{"key":"39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ijc.28662","article-title":"Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis","volume":"135","author":"Libutti","year":"2014","journal-title":"Int J Cancer"},{"key":"40","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1158\/1541-7786.MCR-11-0162","article-title":"Downregulation of Filamin A interacting protein 1-like is associated with promoter methylation and induces an invasive phenotype in ovarian cancer","volume":"9","author":"Kwon","year":"2011","journal-title":"Mol Cancer Res"},{"key":"41","doi-asserted-by":"crossref","first-page":"e82620","DOI":"10.1371\/journal.pone.0082620","article-title":"Down-Regulation of Filamin Ainteracting protein 1-like Is Associated with Promoter Methylation and an Invasive Phenotype in Breast, Colon, Lung and Pancreatic Cancers","volume":"8","author":"Libutti","year":"2013","journal-title":"PLoS One"},{"key":"42","doi-asserted-by":"crossref","first-page":"7332","DOI":"10.1158\/0008-5472.CAN-08-1087","article-title":"Functional characterization of filamin a interacting protein 1-like, a novel candidate for antivascular cancer therapy","volume":"68","author":"Libutti","year":"2008","journal-title":"Cancer Res"},{"key":"43","first-page":"1435","article-title":"Filamin A interacting protein 1-like as a therapeutic target in cancer","volume":"18","author":"Libutti","year":"2014","journal-title":"Expert Opin Ther Targets"},{"key":"44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.juro.2012.08.188","article-title":"CpG Island Hypermethylation Frequently Silences FILIP1L Isoform 2 Expression in Prostate Cancer","volume":"189","author":"Jarrard","year":"2013","journal-title":"J Urol"},{"key":"45","doi-asserted-by":"crossref","first-page":"31397","DOI":"10.1074\/jbc.M111.255851","article-title":"Promotion of heat shock factor Hsf1 degradation via adaptor protein filamin A-interacting protein 1-like (FILIP-1L)","volume":"286","author":"Mivechi","year":"2011","journal-title":"J Biol Chem"},{"key":"46","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/stem.154","article-title":"Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells","volume":"27","author":"Bapat","year":"2009","journal-title":"Stem Cells"},{"key":"47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2407-12-91","article-title":"EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer","volume":"12","author":"Park","year":"2012","journal-title":"BMC Cancer"},{"key":"48","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nmeth.2521","article-title":"Near-infrared fluorescent proteins for multicolorimaging","volume":"10","author":"Verkhusha","year":"2013","journal-title":"Nat Methods"},{"key":"49","doi-asserted-by":"crossref","first-page":"e72162","DOI":"10.1371\/journal.pone.0072162","article-title":"Type-specific cell line models for type-specific ovarian cancer research","volume":"8","author":"Kalloger","year":"2013","journal-title":"PLoS One"},{"key":"50","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrc3144","article-title":"Rethinking ovarian cancer: recommendations for improving outcomes","volume":"11","author":"Gabra","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"51","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nrg1557","article-title":"The centrosome in human genetic disease","volume":"6","author":"Katsanis","year":"2005","journal-title":"Nat Rev Genet"},{"key":"52","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1101\/gad.1596308","article-title":"beta-Catenin is a Nek2 substrate involved in centrosome separation","volume":"22","author":"Barth","year":"2008","journal-title":"Genes Dev"},{"key":"53","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/ng.2007.12","article-title":"Disruption of the basal body compromises proteasomal function and perturbs intracellular Wnt response","volume":"39","author":"Katsanis","year":"2007","journal-title":"Nat Genet"},{"key":"54","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1083\/jcb.145.3.481","article-title":"Dynamic association of proteasomal machinery with the centrosome","volume":"145","author":"Thomas","year":"1999","journal-title":"J Cell Biol"},{"key":"55","doi-asserted-by":"crossref","first-page":"10681","DOI":"10.1074\/jbc.274.16.10681","article-title":"Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability","volume":"274","author":"Kikuchi","year":"1999","journal-title":"J Biol Chem"},{"key":"56","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1038\/sj.onc.1210217","article-title":"A novel role of phospho-beta-catenin in microtubule regrowth at centrosome","volume":"26","author":"Hamaguchi","year":"2007","journal-title":"Oncogene"},{"key":"57","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/embor.2010.23","article-title":"Conductin\/axin2 and Wnt signalling regulates centrosome cohesion","volume":"11","author":"Behrens","year":"2010","journal-title":"EMBO Rep"},{"key":"58","doi-asserted-by":"crossref","first-page":"7732","DOI":"10.1073\/pnas.0803027105","article-title":"Asymmetric mitosis: Unequal segregation of proteins destined for degradation","volume":"105","author":"De Robertis","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"59","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ygyno.2014.03.575","article-title":"The clinical and diagnostic role of microRNAs in ovarian carcinoma","volume":"133","author":"Reich","year":"2014","journal-title":"Gynecol Oncol"},{"key":"60","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.humpath.2015.06.013","article-title":"MicroRNAs in Ovarian Cancer","volume":"46","author":"Davidson","year":"2015","journal-title":"Hum Pathol"},{"key":"61","first-page":"249393","article-title":"The role of microRNAs in ovarian cancer","volume":"2014","author":"Kimura","year":"2014","journal-title":"Biomed Res Int"},{"key":"62","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.3748\/wjg.v20.i15.4276","article-title":"Advances in epigenetic biomarker research in colorectal cancer","volume":"20","author":"Hu","year":"2014","journal-title":"World J Gastroenterol"},{"key":"63","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.semcancer.2015.03.001","article-title":"Broad targeting of resistance to apoptosis in cancer","volume":"35","author":"Russo","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"64","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4252\/wjsc.v7.i1.137","article-title":"Epigenetic therapy of cancer stem and progenitor cells by targeting DNA methylation machineries","volume":"7","author":"Wongtrakoongate","year":"2015","journal-title":"World J Stem Cells"},{"key":"65","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000343860","article-title":"Alteration of Epigenetic Profile in Human Hepatocellular Carcinoma and Its Clinical Implications","volume":"3","author":"Kudo","year":"2014","journal-title":"Liver Cancer"},{"key":"66","first-page":"615","article-title":"Mechanisms and clinical significance of histone deacetylase inhibitors: epigenetic glioblastoma therapy","volume":"35","author":"Das","year":"2015","journal-title":"Anticancer Res"},{"key":"67","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1101\/gr.2552804","article-title":"Early genetic mechanisms underlying the inhibitory effects of endostatin and fumagillin on human endothelial cells","volume":"14","author":"Libutti","year":"2004","journal-title":"Genome Res"},{"key":"68","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cyto.2005.01.020","article-title":"Endothelial monocyte activating polypeptide-II induced gene expression changes in endothelial cells","volume":"30","author":"Libutti","year":"2005","journal-title":"Cytokine"},{"key":"69","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1470-2045(08)70308-5","article-title":"The cell of origin of ovarian epithelial tumours","volume":"9","author":"Dubeau","year":"2008","journal-title":"Lancet Oncol"},{"key":"70","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/jcp.2005.029876","article-title":"Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer","volume":"59","author":"Kosma","year":"2006","journal-title":"J Clin Pathol"},{"key":"71","first-page":"495754","article-title":"Expression profiles of epithelial-mesenchymal transition-associated proteins in epithelial ovarian carcinoma","volume":"2014","author":"Song","year":"2014","journal-title":"Biomed Res Int"},{"key":"72","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/onc.2013.128","article-title":"Multilayer control of the EMT master regulators","volume":"33","author":"Kang","year":"2014","journal-title":"Oncogene"},{"key":"73","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/onc.2012.290","article-title":"c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt\/beta-catenin-ATP-binding cassette G2 signaling","volume":"32","author":"Wong","year":"2013","journal-title":"Oncogene"},{"key":"74","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1158\/1078-0432.CCR-09-2943","article-title":"Targeting Wnt signaling: can we safely eradicate cancer stem cells?","volume":"16","author":"Kahn","year":"2010","journal-title":"Clin Cancer Res"},{"key":"75","first-page":"163","article-title":"ABC transporters in CSCs membranes as a novel target for treating tumor relapse","volume":"5","author":"Colabufo","year":"2014","journal-title":"Front Pharmacol"},{"key":"76","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1093\/carcin\/bgu187","article-title":"Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via beta-catenin\/ABCG2 signaling","volume":"35","author":"Chen","year":"2014","journal-title":"Carcinogenesis"},{"key":"77","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000434726","article-title":"Prognostic Significance of AMP-Dependent Kinase Alpha Expression in Cervical Cancer","volume":"82","author":"Hewitt","year":"2015","journal-title":"Pathobiology"},{"key":"78","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12967-016-0874-0","article-title":"Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients","volume":"14","author":"Hewitt","year":"2016","journal-title":"J Transl Med"},{"key":"79","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1479-5876-11-185","article-title":"Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry","volume":"11","author":"Hewitt","year":"2013","journal-title":"J Transl Med"},{"key":"80","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1136\/jcp.2006.044537","article-title":"Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer","volume":"60","author":"Lugli","year":"2007","journal-title":"J Clin Pathol"},{"key":"81","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ygyno.2012.06.017","article-title":"DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination","volume":"127","author":"Bradford","year":"2012","journal-title":"Gynecol Oncol"},{"key":"82","doi-asserted-by":"crossref","first-page":"R100","DOI":"10.1186\/gb-2006-7-10-r100","article-title":"CellProfiler: image analysis software for identifying and quantifying cell phenotypes","volume":"7","author":"Sabatini","year":"2006","journal-title":"Genome Biol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T02:53:53Z","timestamp":1718852033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,20]]},"references-count":82,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2016,11,22]]}},"alternative-id":["12784","27776341"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.12784","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,20]]}}}